Ozempic and other weight-loss drugs boost pharmacy sales at Rite Aid

United States News News

Ozempic and other weight-loss drugs boost pharmacy sales at Rite Aid
United States Latest News,United States Headlines
  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 27 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 97%

Rite Aid Corp. said Thursday its fiscal first-quarter pharmacy sales got a boost from a new class of drug.

Rite Aid Corp. said Thursday that its fiscal first-quarter pharmacy sales got a boost from a new class of drug.

Still, the company RAD cheered investors by raising its full-year revenue guidance due to the sales bump from Ozempic and other high-dollar GLP-1 drugs. It now expects revenue of $22.6 billion to $23 billion, ahead of the FactSet consensus of $22.3 billion. Ozempic, Rybelsus and Mounjaro have been approved by the Food and Drug Administration for treatment of Type 2 diabetes, while Wegovy is approved for people with obesity and for certain people with excess weight combined with weight-related medical problems.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

MarketWatch /  🏆 3. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Rite Aid’s stock slides to fresh record low ahead of earnings due ThursdayRite Aid’s stock slides to fresh record low ahead of earnings due ThursdayRite Aid Corp.’s stock slid another 3.8% Wednesday to a fresh record low, bringing its five-day loss to 23%. The stock has been under pressure since a...
Read more »

Stock Market News: Regional banks rally, Rite Aid plummets, travel debacle continues in NortheastStock Market News: Regional banks rally, Rite Aid plummets, travel debacle continues in NortheastMarkets have shown renewed optimism after regional banks passed the Federal Reserve's annual stress test. Initial jobless claims cools as economy remains resilient to the Federal Reserve's interest rate hiking campaign. Electric vehicle rollout continues to put pressure on limited resources. FOX Business is providing real-time updates on the markets, commodities and all the most active stocks on the move.
Read more »

Experimental Weight-Loss Drug Retatrutide May Be More Effective Than OzempicExperimental Weight-Loss Drug Retatrutide May Be More Effective Than OzempicStudy participants lost up to 30% of their body weight by the end of the trial—but there are some interesting side effects.
Read more »

Ozempic’s Other Unexpected Side Effect Is All in Your HeadOzempic’s Other Unexpected Side Effect Is All in Your HeadWatch: Diabetes drugs could become an effective way to treat behavioral issues and addiction. danielas_bot breaks down the science on how they work and how they could change psychiatry forever.
Read more »

What Is Ozempic And Why Are People Saying It's a Sad Way to Lose Weight?What Is Ozempic And Why Are People Saying It's a Sad Way to Lose Weight?In their constant search for new ways to stay thin, Hollywood embraced a new fad in 2023 in the form of the injectable type-2 diabetes drug called Ozempic.
Read more »

Ozempic Can Make You Thin, Not Necessarily HealthyOzempic Can Make You Thin, Not Necessarily HealthyDiet and exercise still matter when you take drugs for weight loss, and not only for the reasons you expect.
Read more »



Render Time: 2025-02-21 23:38:38